ORAL GLP-1 DRUGS MAY QUIET THE BRAIN’S FOOD CRAVING CIRCUIT
REPORT A PROBLEM WITH THIS SOURCE
WHAT HAPPENED
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
All Top News -- ScienceDaily reports that newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit.
The report adds: The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.
DAMMNEWS RSS BRIEFING — generated locally from the available All Top News -- ScienceDaily headline and RSS excerpt. It is not a summary of the full source article.
RELATED DAMMNEWS COVERAGE
- APOE2 MAY PROTECT THE BRAIN FROM ALZHEIMER’S AND AGING
Health & Medicine News -- Scienc • 1 day ago • HEALTH - OZEMPIC AND MOUNJARO LINKED TO A SURPRISING HAIR LOSS RISK
Health & Medicine News -- Scienc • 1 day ago • HEALTH - THE BILLION-DOLLAR PROBLEM KEEPING OZEMPIC, WEGOVY, AND ZEPBOUND FROM PATIENTS
Health & Medicine News -- Scienc • 1 day ago • HEALTH